Literature DB >> 12236636

Donepezil for memory dysfunction in schizophrenia.

Andrew K Howard1, Allen E Thornton, Siemion Altman, William G Honer.   

Abstract

A case is reported of a 54-year-old female patient with schizophrenia and cognitive impairment. Her memory dysfunction improved following the addition of donepezil to quetiapine. The possible implications for future studies are reviewed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12236636     DOI: 10.1177/026988110201600313

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  5 in total

Review 1.  Relevance of donepezil in enhancing learning and memory in special populations: a review of the literature.

Authors:  J Helen Yoo; Maria G Valdovinos; Dean C Williams
Journal:  J Autism Dev Disord       Date:  2007-01-13

Review 2.  Clinically significant drug interactions with cholinesterase inhibitors: a guide for neurologists.

Authors:  Danièle Bentué-Ferrer; Olivier Tribut; Elisabeth Polard; Hervé Allain
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

3.  High-dose galantamine augmentation inferior to placebo on attention, inhibitory control and working memory performance in nonsmokers with schizophrenia.

Authors:  Michael A Dyer; Oliver Freudenreich; Melissa A Culhane; Gladys N Pachas; Thilo Deckersbach; Erin Murphy; Donald C Goff; A Eden Evins
Journal:  Schizophr Res       Date:  2008-03-05       Impact factor: 4.939

4.  Predictors of early abstinence in smokers with schizophrenia.

Authors:  Melissa A Culhane; David A Schoenfeld; Ruth S Barr; Corinne Cather; Thilo Deckersbach; Oliver Freudenreich; Donald C Goff; Nancy A Rigotti; A Eden Evins
Journal:  J Clin Psychiatry       Date:  2008-10-21       Impact factor: 4.384

Review 5.  The role of acetylcholinesterase inhibitors such as neostigmine and rivastigmine on chronic pain and cognitive function in aging: A review of recent clinical applications.

Authors:  Jabril Eldufani; Gilbert Blaise
Journal:  Alzheimers Dement (N Y)       Date:  2019-06-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.